The Fifth CRI-CIMT-EATI-AACR CICON takes place September 25-28, 2019, at Espace Grand Arche de la Défense in Paris, France.
The Sixth CRI-CIMT-EATI-AACR CICON takes place September 13-16, 2020, at the New York Marriott Marquis in New York City.
CRI members receive a 20% off registration to the 5th annual Immuno-Oncology 360° in New York City.
The fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, held in New York City, is devoted to exploring the latest research in cancer immunology and immunotherapy.
Rational Combinations 360° is a comprehensive program providing exposure to the entire spectrum of research and development, addressing key aspects across all facets of combination immunotherapies.
CRI scientists are presenting at the Annual Meeting of the American Society of Clinical Oncologists. CRI is providing a daily recap of new work coming out of the conference.
This two-day scientific conference will convene experts in oncology and immunology to discuss emerging approaches, challenges, and opportunities faced in the rapidly evolving field of cancer immunotherapy.
Many CRI-funded and -affiliated scientists and clinicians will be showcased at the American Association of Cancer Research Annual Meeting on April 14-18, 2018, in Chicago, Illinois.
On April 12, our chief medical officer, Aiman Shalabi, will be a featured expert on the panel, “Immuno-Oncology: Challenges & Opportunities”.
Dr. Jill O’Donnell-Tormey, CEO and director of scientific affairs, will participate in the 'Weaponizing Your Own Body' panel on Tuesday, March 20, 2018 at 7:45 am.
The fourth annual Immuno-Oncology 360° meeting will be held on February 7-9, 2018 at the Roosevelt Hotel, New York City.
Dr. Vanessa Lucey, associate director, CRI Venture Fund & Clinical Accelerator, is speaking during the "Back to Basics" session on January 23, 2018 at 2:00 p.m.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
An interview with bestselling author Charles Graeber about his new book, The Breakthrough: Immunotherapy and the Race to Cure Cancer.
Dr. Jill O’Donnell-Tormey participated in an expert panel discussion on rare cancers for The Forum at the Harvard T.H. Chan School of Public Health in February 2019.